📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CAR T-Cells Targeting the Integrin avß6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies. (2019)

First Author: Whilding LM

Attributed to: King's Health Partners Confidence in Concept funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cancers11050674

PubMed Identifier: 31091832

Publication URI: http://europepmc.org/abstract/MED/31091832

Type: Journal Article/Review

Volume: 11

Parent Publication: Cancers

Issue: 5

ISSN: 2072-6694